magdy elmasry
270
Seguidores
Personal Information
Organização/Local de trabalho
Egypt Egypt
Cargo
professor of cardiology at Tanta University
Setor
Medical / Health Care / Pharmaceuticals
Marcadores
debate on central blood press
residual cv risk in treated h
hypertension and total cv risk
in friedreich ataxia
cardiovascular involvement
diagnosis and management of
dyslipidemia in special popula
introducing nephro-cardiology
anti-anginal drugs
impact of non-adherence to antihypertensive medica
the five dimensions of non-adherence
benefit-risk profile of sglt2 inhibitors ( glifloz
several sglt2 inhibitors have completed phase 3 cl
similarities and differences between hfa and inter
noninvasive multimodality imaging in the diagnosi
74:905–27 )
jacc scientific expert panel ( j am coll cardiol 2
radiation associated cardiac disease
cardiac evaluation algorithm for liver transplant
connections between hepatic and cardiovascular dis
shifting the paradigm in diabetes care treating di
anti-diabetics for cardiac patients the proper sel
board scheme for the therapy of patients with acut
peripartum cardiomyopathy
t3 has both genomic and nongenomic effects on the
thyroid hormones and cardiovascular function and d
which as their modes of action suggest oppose each
the cornerstones of therapy are beta-blockers and
association of cardiovascular disease with respira
the clinical challenge of concomitant aortic and m
challenges in multivalvular disease
should you use doacs for cancer-associated vte?.cr
from hypertension to heart failure
role of the renin–angiotensin–aldosterone system i
cardio-renal protection through renin–angiotensin
fourth universal definition of myocardial infarcti
psychopharmacology and cardiovascular disease
obesity and cardiovascular disease
iron therapy for the treatment of iron deficiency
vitamin d and cardiovascular disease where do we s
what is diuretic resistance?how to tackle congesti
myocardial infarction with non-obstructive corona
minoca
new guidelines for managing patients with high blo
perioperative management of hypertension
blood pressure targets 2017.still struggling f
esc 2016 risk categories & ldl goal
recommendations for treatment targets for ldl-c
pros and cons of anticoagulants in cirrhotic patie
arrhythmia-induced cardiomyopathy
precautions to minimize exposure to patient and dr
ticagrelor versus clopidogrel
acute coronary syndrome.dual antiplatelet therapy.
cardiac amyloidosis
acute coronary syndrome
dual antiplatelet therapy
invidualised antiplatelet therapy
percutaneous coronary intervention
ppi
dapt and oral anticoagulants
hypertension and coronary artery disease
new guidelines 2015
jnc8 controversy
blood pressure targets
hypertension 2014-2015 guidelines
antianginal drugs
stable coronary artery
esc guidelines 2013
2014
european society of cardiology guidelines
hypertrophic cardiomyopathy
leaflet motion
cinefluoroscopy
prosthetic
jnc 8 -2014
esh/esc 2013
microvascular angina
Ver mais
- Apresentações
- Documentos
- Infográficos